Jane Street’s ImageneBio Inc IMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66K Sell
13,210
-1,686
-11% -$10.9K ﹤0.01% 10860
2025
Q4
$103K Buy
+14,896
New +$110K ﹤0.01% 10175
2024
Q4
Sell
-3,106
Closed -$64.5K 9956
2024
Q3
$64.5K Sell
3,106
-1,547
-33% -$31.3K ﹤0.01% 9123
2024
Q2
$92.1K Buy
+4,653
New +$82.2K ﹤0.01% 8758
2024
Q1
Sell
-1,839
Closed -$43.5K 9604
2023
Q4
$43.5K Buy
+1,839
New +$60K ﹤0.01% 8806
2023
Q2
Sell
-3,193
Closed -$132K 9095
2023
Q1
$132K Buy
+3,193
New +$147K ﹤0.01% 8080

Other funds holding IMA

Jane Street's IMA Position: Q1 2026 in Review

Jane Street reduced its ImageneBio Inc (IMA) stake by 11% in Q1 2026, selling an estimated $10.9K and leaving 13,210 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #10860.

Jane Street first reported a position in IMA in Q1 2023 and has held it in 6 quarters since. The position peaked at $132K in Q1 2023. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Jane Street held 13,210 shares of ImageneBio Inc worth $66K as of Q1 2026.
  • Jane Street sold 1,686 ImageneBio Inc shares in Q1 2026, an estimated $10.9K.
  • ImageneBio Inc made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10860 holding.
  • Jane Street first reported a position in ImageneBio Inc in Q1 2023 and has held it in 6 quarters since.
  • Jane Street's ImageneBio Inc position peaked at $132K in Q1 2023.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.